Professor and Dean, School of Pharmacy
University of California, San Francisco
Kathleen M. Giacomini, Ph.D.
Kathy Giacomini, professor and dean in the School of Pharmacy at the University of California, San Francisco, is a leader in the field of membrane transporters with a focus on genetic polymorphisms. She cloned, characterized and discovered the endogenous role of the human xenobiotic transporter, OCT1 (SLC22A1), and recently de-orphaned SLC22A10, SLC22A15, and SLC22A24 discovering physiologic and pharmacologic substrates of these transporters. Together with others, she co-founded the International Transporter Consortium, which has published highly impactful papers informing regulatory policy. She is the Co-Principal Investigator of the UCSF-Stanford Center of Excellence in Regulatory Sciences and Innovation, funded by the Food and Drug Administration. She has received numerous awards including an honorary doctorate degree from Uppsala University, and is an elected member of the National Academy of Medicine.
Disclosure(s): No financial relationships to disclose
Is Pharmacogenetic Testing a Vital Tool for Enhancing Therapeutic Management of Patients Worldwide?
Thursday, March 28, 2024
9:30 AM – 10:30 AM MDT
Oscar B. Hunter Career Award in Therapeutics Lecture
Friday, March 29, 2024
11:00 AM – 11:45 AM MDT